Even FDA-approved medicines have side effects, sometimes serious ones, he pointed out
In animal models, TB-500 increased re-epithelialization rates and accelerated wound closure compared to placebo controls.- Clinical trials with thymosin beta-4 analogues showed improved outcomes in patients with chronic pressure ulcers.- BPC-157 studies demonstrated higher collagen deposition, angiogenesis, and granulation tissue formation in injured tissue models
While improved recovery capacity may indirectly support training performance, BPC-157 is not typically classified as a primary muscle-building peptide in growth hormonefocused research
Many athletes make the mistake of either complete inactivity or premature return to normal training, both of which can compromise outcomes
Side effects: generally resolved
This situation emphasizes the importance of proper clinical development for peptide therapeutics